Position in RGNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,024,299
+$3,374,305 QoQ
Shares Held
669,808
+20.7% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#16
of 163 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. RGNX ranks #91 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in RGNX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,024,299 | 669,808 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,649,994 | 554,892 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,871,150 | 129,941 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,488,859 | 154,286 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,707,277 | 207,951 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,335,962 | 326,708 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,010,278 | 389,428 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,321,037 | 125,933 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,102,958 | 179,740 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,895,962 | 89,984 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,065,524 | 115,071 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $497,289 | 30,212 | Shares | Sole | 2023-11-14 | |
| 2022-09-30 | $1,040,337 | 39,362 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $385,004 | 11,600 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $6,329,668 | 150,994 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $722,610 | 18,600 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,045,650 | 118,606 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $367,416 | 8,100 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $246,028 | 8,940 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,609,139 | 43,691 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||